CNSP · CNS Pharmaceuticals, Inc.
Market Cap
$8.43M
Shares
1.46M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-27 | 1,177 | 10,340 | 11,517 | 43.9% |
| 2026-07-20 | 3,257 | 30,568 | 33,825 | 49.3% |
| 2026-07-13 | 599 | 17,484 | 18,083 | 60.9% |
| 2026-07-06 | 10,097 | 22,449 | 32,546 | 56.1% |
| 2026-06-29 | 3,906 | 23,027 | 26,933 | 50.1% |
| 2026-06-22 | 5,650 | 21,133 | 26,783 | 50.3% |
| 2026-06-15 | 3,307 | 20,734 | 24,041 | 39.5% |
| 2026-06-08 | 13,900 | 55,200 | 69,100 | 51.1% |
| 2026-06-01 | 3,745 | 42,367 | 46,112 | 52.6% |
| 2026-05-25 | 25,528 | 403,273 | 428,801 | 39.5% |
| 2026-05-18 | 14,067 | 72,963 | 87,030 | 56.4% |
| 2026-05-11 | 57,885 | 207,052 | 264,937 | 50.6% |
| 2026-05-04 | 2,239,065 | 36,807,501 | 39,046,566 | 45.3% |
| 2026-04-27 | 821 | 20,828 | 21,649 | 60.6% |
| 2026-04-20 | 7,531 | 62,260 | 69,791 | 51.7% |
| 2026-04-13 | 17,448 | 83,640 | 101,088 | 49.1% |
| 2026-04-06 | 5,845 | 47,402 | 53,247 | 44.7% |
| 2026-03-30 | 3,635 | 18,859 | 22,494 | 42.6% |
| 2026-03-23 | 12,573 | 45,326 | 57,899 | 17.1% |
| 2026-03-16 | 7,442 | 70,135 | 77,577 | 46.1% |
| 2026-03-09 | 17,722 | 129,982 | 147,704 | 34.6% |
| 2026-03-02 | 4,056 | 36,467 | 40,523 | 51.6% |
| 2026-02-23 | 4,495 | 32,027 | 36,522 | 57.7% |
| 2026-02-16 | 3,458 | 28,943 | 32,401 | 42.5% |
| 2026-02-09 | 10,434 | 91,160 | 101,594 | 58.8% |
| 2026-02-02 | 5,472 | 34,460 | 39,932 | 47.0% |
| 2026-01-26 | 5,202 | 52,284 | 57,486 | 50.2% |
| 2026-01-19 | 8,796 | 53,363 | 62,159 | 45.9% |
| 2026-01-12 | 49,018 | 593,753 | 642,771 | 56.7% |
| 2026-01-05 | 3,407 | 36,898 | 40,305 | 62.2% |
| 2025-12-29 | 3,771 | 46,389 | 50,160 | 66.4% |
| 2025-12-22 | 4,101 | 59,968 | 64,069 | 52.3% |
| 2025-12-15 | 9,582 | 61,302 | 70,884 | 65.0% |
| 2025-12-08 | 6,894 | 62,621 | 69,515 | 65.5% |
| 2025-12-01 | 1,999 | 14,840 | 16,839 | 51.5% |
| 2025-11-24 | 1,600 | 14,650 | 16,250 | 57.6% |
| 2025-11-17 | 2,840 | 16,397 | 19,237 | 58.6% |
| 2025-11-10 | 4,590 | 52,450 | 57,040 | 38.1% |
| 2025-11-03 | 3,326 | 21,915 | 25,241 | 40.3% |
| 2025-10-27 | 4,395 | 33,410 | 37,805 | 52.0% |
| 2025-10-20 | 5,608 | 33,541 | 39,149 | 49.5% |
| 2025-10-13 | 9,453 | 27,707 | 37,160 | 45.7% |
| 2025-10-06 | 48,333 | 153,764 | 202,097 | 67.5% |
| 2025-09-29 | 4,022 | 20,848 | 24,870 | 59.1% |
| 2025-09-22 | 6,026 | 27,188 | 33,214 | 49.6% |
| 2025-09-15 | 18,026 | 180,330 | 198,356 | 28.1% |
| 2025-09-08 | 8,135 | 54,426 | 62,561 | 51.2% |
Showing 1–47 of 47 weeks
Key facts
CIK
1729427
CUSIP
18978H508
13F (30d)
11 filings
10 filers
Visit website
Investor relations